Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
13.1M
-
Shares change
-
+1.48M
-
Total reported value, excl. options
-
$45.7M
-
Value change
-
+$5.57M
-
Put/Call ratio
-
0.18
-
Number of buys
-
36
-
Number of sells
-
-14
-
Price
-
$3.48
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q1 2024
74 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q1 2024.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.1M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (3.05M shares), Tieton Capital Management, LLC (3.02M shares), ICONIQ Capital, LLC (1.3M shares), BlackRock Inc. (903K shares), MILLENNIUM MANAGEMENT LLC (584K shares), GEODE CAPITAL MANAGEMENT, LLC (561K shares), RENAISSANCE TECHNOLOGIES LLC (384K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (270K shares), GAMCO INVESTORS, INC. ET AL (264K shares), and JANE STREET GROUP, LLC (228K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.